152 related articles for article (PubMed ID: 32945473)
1. Xanthohumol targets the ERK1/2‑Fra1 signaling axis to reduce cyclin D1 expression and inhibit non‑small cell lung cancer.
Gao F; Li M; Zhou L; Liu W; Zuo H; Li W
Oncol Rep; 2020 Oct; 44(4):1365-1374. PubMed ID: 32945473
[TBL] [Abstract][Full Text] [Related]
2. Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells.
Sławińska-Brych A; Zdzisińska B; Dmoszyńska-Graniczka M; Jeleniewicz W; Kurzepa J; Gagoś M; Stepulak A
Toxicology; 2016 May; 357-358():65-73. PubMed ID: 27317025
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
4. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
[TBL] [Abstract][Full Text] [Related]
5. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
6. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of cyclin D1 via HER2/HER3 contributes to EGFR-TKI resistance in lung cancer.
Liu B; Chen D; Chen S; Saber A; Haisma H
Biochem Pharmacol; 2020 Aug; 178():114095. PubMed ID: 32535106
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
Liu X; Song M; Wang P; Zhao R; Chen H; Zhang M; Shi Y; Liu K; Liu F; Yang R; Li E; Bode AM; Dong Z; Lee MH
Int J Cancer; 2019 Aug; 145(4):1007-1019. PubMed ID: 30887517
[TBL] [Abstract][Full Text] [Related]
10. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
11. Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis.
Liu W; Li W; Liu H; Yu X
Int J Biol Sci; 2019; 15(11):2497-2508. PubMed ID: 31595166
[TBL] [Abstract][Full Text] [Related]
12. Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation.
Liu Y; Gao X; Deeb D; Arbab AS; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2012; 10(1):1-8. PubMed ID: 22946339
[TBL] [Abstract][Full Text] [Related]
13. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
14. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model.
Tang FY; Chiang EP; Pai MH
J Agric Food Chem; 2010 Oct; 58(20):11156-64. PubMed ID: 20866043
[TBL] [Abstract][Full Text] [Related]
15. The coffee diterpene kahweol suppresses the cell proliferation by inducing cyclin D1 proteasomal degradation via ERK1/2, JNK and GKS3β-dependent threonine-286 phosphorylation in human colorectal cancer cells.
Park GH; Song HM; Jeong JB
Food Chem Toxicol; 2016 Sep; 95():142-8. PubMed ID: 27424123
[TBL] [Abstract][Full Text] [Related]
16. [Interleukin 7 and its receptor promote cell proliferation and induce lymphangiogenesis in non-small cell lung cancer].
Ming J; Zhang QF; Jiang YD; Jiang GC; Qiu XS
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):511-8. PubMed ID: 23157741
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.
Kobayashi S; Shimamura T; Monti S; Steidl U; Hetherington CJ; Lowell AM; Golub T; Meyerson M; Tenen DG; Shapiro GI; Halmos B
Cancer Res; 2006 Dec; 66(23):11389-98. PubMed ID: 17145885
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ERK1/2 Signaling Pathway is Involved in Melatonin's Antiproliferative Effect on Human MG-63 Osteosarcoma Cells.
Liu L; Xu Y; Reiter RJ; Pan Y; Chen D; Liu Y; Pu X; Jiang L; Li Z
Cell Physiol Biochem; 2016; 39(6):2297-2307. PubMed ID: 27832629
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1.
Di Desidero T; Fioravanti A; Orlandi P; Canu B; Giannini R; Borrelli N; Man S; Xu P; Fontanini G; Basolo F; Kerbel RS; Francia G; Danesi R; Bocci G
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1465-73. PubMed ID: 23969186
[TBL] [Abstract][Full Text] [Related]
20. Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3.
Tang X; McMullen TPW; Brindley DN
Theranostics; 2019; 9(21):6129-6142. PubMed ID: 31534541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
